Taimur Sher

4.4k total citations
124 papers, 2.1k citations indexed

About

Taimur Sher is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Taimur Sher has authored 124 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Hematology, 52 papers in Oncology and 41 papers in Molecular Biology. Recurrent topics in Taimur Sher's work include Multiple Myeloma Research and Treatments (58 papers), Chronic Lymphocytic Leukemia Research (32 papers) and Protein Degradation and Inhibitors (21 papers). Taimur Sher is often cited by papers focused on Multiple Myeloma Research and Treatments (58 papers), Chronic Lymphocytic Leukemia Research (32 papers) and Protein Degradation and Inhibitors (21 papers). Taimur Sher collaborates with scholars based in United States, Spain and Lebanon. Taimur Sher's co-authors include Grace K. Dy, Alex A. Adjei, Asher Chanan‐Khan, Morie A. Gertz, Sikander Ailawadhi, Angela Dispenzieri, Aneel Paulus, Vivek Roy, Kena C. Miller and Ricardo Parrondo and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Taimur Sher

113 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Taimur Sher United States 24 993 795 574 419 362 124 2.1k
Faiz Anwer United States 23 1.1k 1.2× 782 1.0× 963 1.7× 275 0.7× 342 0.9× 328 2.5k
Samuel A. Jacobs United States 25 1.4k 1.4× 620 0.8× 279 0.5× 753 1.8× 356 1.0× 143 2.9k
Brian T. Hill United States 27 1.2k 1.2× 746 0.9× 482 0.8× 962 2.3× 790 2.2× 225 2.7k
Leona Holmberg United States 24 809 0.8× 654 0.8× 1.0k 1.8× 442 1.1× 361 1.0× 99 2.2k
Sikander Ailawadhi United States 28 1.4k 1.4× 1.1k 1.4× 1.7k 2.9× 368 0.9× 620 1.7× 312 3.1k
Celalettin Üstün United States 29 664 0.7× 866 1.1× 1.6k 2.8× 170 0.4× 498 1.4× 147 3.0k
Diane van der Woude Netherlands 32 422 0.4× 606 0.8× 463 0.8× 289 0.7× 343 0.9× 85 4.1k
B. Grosbois France 26 636 0.6× 1.3k 1.7× 1.2k 2.1× 328 0.8× 780 2.2× 118 2.6k
Hansjörg Riehm Germany 21 1.1k 1.1× 943 1.2× 1.1k 2.0× 578 1.4× 322 0.9× 32 3.5k
Jianmin Wang China 26 700 0.7× 820 1.0× 1.3k 2.3× 222 0.5× 429 1.2× 141 2.7k

Countries citing papers authored by Taimur Sher

Since Specialization
Citations

This map shows the geographic impact of Taimur Sher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taimur Sher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taimur Sher more than expected).

Fields of papers citing papers by Taimur Sher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taimur Sher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taimur Sher. The network helps show where Taimur Sher may publish in the future.

Co-authorship network of co-authors of Taimur Sher

This figure shows the co-authorship network connecting the top 25 collaborators of Taimur Sher. A scholar is included among the top collaborators of Taimur Sher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taimur Sher. Taimur Sher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ailawadhi, Sikander, Ryan D. Frank, David O. Hodge, et al.. (2024). Factors determining utilization of stem cell transplant for initial therapy of multiple myeloma by patient race: exploring intra-racial healthcare disparities. Blood Cancer Journal. 14(1). 86–86. 5 indexed citations
2.
Parrondo, Ricardo, et al.. (2023). Patient Awareness of CAR-T and Bispecific Antibody Treatments for Multiple Myeloma: Real-World Learnings and Disparities. Blood. 142(Supplement 1). 2418–2418. 2 indexed citations
3.
Ailawadhi, Sikander, Ricardo Parrondo, Vivek Roy, et al.. (2023). The digital divide: Racial disparities in adoption and utilization of health information technology among patients with lymphoid cancers. Cancer Medicine. 12(18). 19013–19020. 2 indexed citations
4.
Parrondo, Ricardo, Muhamad Alhaj Moustafa, Craig B. Reeder, et al.. (2021). Efficacy of Daratumumab-Based Regimens for the Treatment of Plasma Cell Leukemia. Clinical Lymphoma Myeloma & Leukemia. 21(5). 355–360. 9 indexed citations
5.
Sher, Taimur, Charles D. Burger, Erin S. DeMartino, Alice Gallo de Moraes, & Richard R. Sharp. (2020). Resuscitation and COVID-19: Recalibrating Patient and Family Expectations During a Pandemic. Mayo Clinic Proceedings. 95(9). 1848–1851. 2 indexed citations
6.
Bartlett, Nancy L., Alex F. Herrera, Eva Domingo‐Doménech, et al.. (2020). A phase 1b study of AFM13 in combination with pembrolizumab in patients with relapsed or refractory Hodgkin lymphoma. Blood. 136(21). 2401–2409. 107 indexed citations
7.
Menke, David M., et al.. (2020). Use of Tocilizumab in Management of Post-Operative Myelomonocytic Leukemoid Reaction. Leukemia Research Reports. 14. 100228–100228. 1 indexed citations
8.
Iqbal, Madiha, Aaron Spaulding, Shehzad K. Niazi, et al.. (2020). Impact of Depression and Anxiety on Opioid Use in Hospitalized Hematopoietic Cell Transplantation Recipients. Psychosomatics. 61(4). 363–370. 1 indexed citations
9.
Kumar, Vivek, Sikander Ailawadhi, Aditya Mehta, et al.. (2019). Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia. Blood Cancer Journal. 9(10). 75–75. 44 indexed citations
10.
Manna, Alak, Salman Ahmed, Sharoon Akhtar, et al.. (2019). Targeting CD38 Enhances the Antileukemic Activity of Ibrutinib in Chronic Lymphocytic Leukemia. Clinical Cancer Research. 25(13). 3974–3985. 31 indexed citations
11.
Iqbal, Madiha, et al.. (2019). Intraocular involvement of Mantle cell lymphoma. Hematology/Oncology and Stem Cell Therapy. 14(2). 147–152. 3 indexed citations
12.
Iqbal, Madiha, Tea Reljic, Ernesto Ayala, et al.. (2019). Efficacy of Allogeneic Hematopoietic Cell Transplantation in Cutaneous T Cell Lymphoma: Results of a Systematic Review and Meta-Analysis. Biology of Blood and Marrow Transplantation. 26(1). 76–82. 20 indexed citations
13.
Parrondo, Ricardo & Taimur Sher. (2019). <p>Prevention Of Skeletal Related Events In Multiple Myeloma: Focus On The RANK-L Pathway In The Treatment Of Multiple Myeloma</p>. OncoTargets and Therapy. Volume 12. 8467–8478. 8 indexed citations
14.
Dholaria, Bhagirathbhai, Prakash Vishnu, Vivek Roy, et al.. (2017). DA.R-EPOCH Vs. R-CHOP for High-Risk Diffuse Large B- Cell Lymphoma: The Mayo Clinic Florida Experience. Blood. 130. 1572–1572.
15.
16.
Crozier, Jennifer A., Taimur Sher, Dongyun Yang, et al.. (2015). Persistent Disparities Among Patients With T-Cell Non-Hodgkin Lymphomas and B-Cell Diffuse Large Cell Lymphomas Over 40 Years: A SEER Database Review. Clinical Lymphoma Myeloma & Leukemia. 15(10). 578–585. 27 indexed citations
17.
18.
Sher, Taimur, Sikander Ailawadhi, Kena C. Miller, et al.. (2011). A steroid‐independent regimen of bortezomib, liposomal doxorubicin and thalidomide demonstrate high response rates in newly diagnosed multiple myeloma patients. British Journal of Haematology. 154(1). 104–110. 10 indexed citations
19.
Sher, Taimur, Kena C. Miller, George Deeb, Kelvin Lee, & Asher Chanan‐Khan. (2010). Plasma cell leukaemia and other aggressive plasma cell malignancies. British Journal of Haematology. 150(4). 418–427. 29 indexed citations
20.
Sher, Taimur, Kena C. Miller, Kelvin Lee, & Asher Chanan‐Khan. (2009). Remission Induction With Lenalidomide Alone in a Patient With Previously Untreated Plasmablastic Myeloma: A Case Report. Clinical Lymphoma & Myeloma. 9(4). 328–330. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Faiz Anwer Breakdown of academic impact, for papers by Samuel A. Jacobs Breakdown of academic impact, for papers by Brian T. Hill Breakdown of academic impact, for papers by Leona Holmberg Breakdown of academic impact, for papers by Sikander Ailawadhi Breakdown of academic impact, for papers by Celalettin Üstün Breakdown of academic impact, for papers by Diane van der Woude Breakdown of academic impact, for papers by B. Grosbois Breakdown of academic impact, for papers by Hansjörg Riehm Breakdown of academic impact, for papers by Jianmin Wang
Rankless by CCL
2026